ADMA Biologics Inc.
ADMA | NASDAQ
$9.51
+$0.40 (+4.39%)
At close: Sep 21, 2026, 4:00 PM ET
$9.49
-$0.02 (-0.21%)
Pre-market:
Sep 22, 2026, 8:18 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 37.82M | 45.33M | 49.38M | 36.43M | 34.22M | 26.9M | 111.9M | 35.91M | 32.06M | 17.81M | -17.64M | 2.57M | -6.37M | -6.79M | -12.23M | -14.9M | -13.76M | -25.01M | -16.65M | -17.71M | -18.91M | -18.38M |
Depreciation & Amortization | 1.78M | 1.84M | 2.05M | 2.02M | 2.06M | 1.97M | 1.94M | 1.94M | 2.27M | 2.11M | 2.11M | 2.81M | 2.1M | 2.03M | 1.94M | 1.86M | 1.72M | 1.59M | 1.52M | 1.42M | 1.33M | 1.23M |
Stock-Based Compensation | 6.14M | 6.33M | 5.39M | 5.05M | 4.96M | 4.62M | 5.43M | 3.18M | 2.86M | 2.14M | 1.75M | 1.7M | 1.64M | 1.11M | 1.07M | 1.31M | 1.19M | 1.64M | 1.21M | 688.27K | 805.19K | 781.4K |
Other Working Capital | -3.05M | 3.54M | 10.24M | 707K | -2.68M | -5.53M | 8.07M | -5.82M | -7.09M | 2.06M | 4.5M | -206K | 3.82M | -536K | 6.93M | 1.56M | -423.54K | -1.67M | 3.48M | 1.89M | 3.73M | -3.61M |
Other Non-Cash Items | -3.65M | -7.78M | 170K | 2.31M | 1.28M | 154K | -82.78M | 224K | -1.89M | 240K | 27.78M | 1.04M | 1.64M | 1.45M | 1.85M | 1.93M | 1.35M | 7.22M | 607.8K | 450.28K | 428.65K | 408.09K |
Deferred Income Tax | 3K | 3.29M | 1.17M | 4.8M | 1.62M | 3.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.34K | 77.35K | 781 |
Change in Working Capital | -12.56M | 9.24M | -22.52M | -37.32M | -23M | -56.75M | 13.72M | -16.22M | 10.34M | -24.52M | 3.6M | 3.87M | -5.06M | -12.53M | -2.89K | -3.49M | -3.33M | -11.46M | -20.15M | 1.74M | -15.99M | -17.27M |
Operating Cash Flow | 29.54M | 58.25M | 35.64M | 13.29M | 21.14M | -19.68M | 50.22M | 25.03M | 45.65M | -2.22M | 17.6M | 11.99M | -6.06M | -14.72M | -7.38M | -13.28M | -12.83M | -26.01M | -33.47M | -13.41M | -32.26M | -33.23M |
Capital Expenditures | -2.26M | -2.54M | -1.08M | -14.37M | -2.42M | -4.7M | -2.76M | -1.06M | -2.07M | -2.35M | -1.2M | -757K | -872.63K | -1.95M | -3.75M | -3.38M | -3.94M | -2.84M | -3.68M | -2.79M | -4.48M | -2.57M |
Cash Acquisitions | -5M | 5M | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 4.95M | n/a | -192K | n/a | -105K | -19K | 7K | n/a | -299K | -15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -2.26M | 2.4M | -276K | -14.37M | -2.53M | -4.72M | -2.75M | -1.1M | -2.37M | -2.36M | -1.41M | -757K | -872.63K | -1.95M | -3.75M | -3.38M | -3.94M | -2.84M | -3.68M | -2.79M | -4.48M | -2.57M |
Debt Repayment | -469K | 124.53M | 549K | -3.27M | -450K | n/a | -30M | -30M | n/a | n/a | -38.66M | n/a | -6.47K | -10K | -9.4K | -9.25K | -9.09K | 51.74M | -8.79K | -8.65K | -8.5K | -8.36K |
Common Stock Repurchased | -25.05M | -130.19M | -8.9M | -23.04M | n/a | -7.23M | -644K | n/a | -693K | -2.48M | n/a | -208K | 471.55K | -640K | n/a | -429.98K | -309.95K | -91.37K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3.93M | -5.06M | -1.2M | -1.9M | -1.57M | 101K | -382K | -1.16M | 331K | 1.03M | -340.45K | 624K | -224.97K | n/a | -1.89M | -404.56K | n/a | -4.38M | n/a | -2.29K | n/a | -59.31K |
Financial Cash Flow | -29.42M | -10.13M | -9.12M | -27.83M | 48K | -7.13M | -31.03M | -25.47M | -362K | -1.45M | -38.99M | 416K | 240.12K | -650K | 62.74M | -843.79K | -319.04K | 47.27M | 53.82M | 8.2M | 17.18M | 41.84M |
Net Cash Flow | -2.13M | 50.52M | 26.25M | -28.9M | 18.66M | -31.52M | 16.44M | -1.54M | 42.92M | -6.03M | -22.8M | 11.64M | -6.69M | -17.32M | 51.62M | -17.51M | -17.09M | 18.42M | 16.68M | -8M | -19.56M | 6.04M |
Free Cash Flow | 27.28M | 55.71M | 34.56M | -1.08M | 18.72M | -24.38M | 47.46M | 23.97M | 43.58M | -4.56M | 16.4M | 11.23M | -6.93M | -16.67M | -11.13M | -16.67M | -16.77M | -28.86M | -37.14M | -16.2M | -36.74M | -35.8M |
Adj. Free Cash Flow | 21.15M | 49.38M | 29.16M | -6.12M | 13.75M | -29M | 42.03M | 20.79M | 40.72M | -6.71M | 14.65M | 9.53M | -8.57M | -17.78M | -12.2M | -17.98M | -17.96M | -30.5M | -38.35M | -16.89M | -37.54M | -36.58M |
Maintenance CapEx | -1.78M | -1.84M | n/a | -10.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -475K | -704K | -1.08M | -3.87M | -2.42M | -4.7M | -2.76M | -1.06M | -2.07M | -2.35M | -1.2M | -757K | -872.63K | -1.95M | -3.75M | -3.38M | -3.94M | -2.84M | -3.68M | -2.79M | -4.48M | -2.57M |
Owner Earnings | 27.76M | 56.41M | 35.64M | 2.8M | 21.14M | -19.68M | 50.22M | 25.03M | 45.65M | -2.22M | 17.6M | 11.99M | -6.06M | -14.72M | -7.38M | -13.28M | -12.83M | -26.01M | -33.47M | -13.41M | -32.26M | -33.23M |
Add to Watchlist
Select watchlists to add or remove ADMA